KR880701244A - 위치 17에 스피로 고리가 있는 스테로이드, 이들의 제조 방법 및 중간체 약제로서 이들의 사용, 및 이들을 함유하는 약제학적 조성물 - Google Patents

위치 17에 스피로 고리가 있는 스테로이드, 이들의 제조 방법 및 중간체 약제로서 이들의 사용, 및 이들을 함유하는 약제학적 조성물

Info

Publication number
KR880701244A
KR880701244A KR1019870701100A KR870701100A KR880701244A KR 880701244 A KR880701244 A KR 880701244A KR 1019870701100 A KR1019870701100 A KR 1019870701100A KR 870701100 A KR870701100 A KR 870701100A KR 880701244 A KR880701244 A KR 880701244A
Authority
KR
South Korea
Prior art keywords
steroids
preparation
methods
pharmaceutical compositions
compositions containing
Prior art date
Application number
KR1019870701100A
Other languages
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of KR880701244A publication Critical patent/KR880701244A/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J33/00—Normal steroids having a sulfur-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J33/002—Normal steroids having a sulfur-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0077—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0077—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom
    • C07J41/0083—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom substituted in position 11-beta by an optionally substituted phenyl group not further condensed with other rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
KR1019870701100A 1986-03-26 1987-11-25 위치 17에 스피로 고리가 있는 스테로이드, 이들의 제조 방법 및 중간체 약제로서 이들의 사용, 및 이들을 함유하는 약제학적 조성물 KR880701244A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8604355A FR2596395B1 (fr) 1986-03-26 1986-03-26 Nouveaux steroides comportant un cycle spirannique en position 17, leur procede de preparation, leur application comme medicaments et les compositions les renfermant
PCT/FR1987/000096 WO1987005908A1 (fr) 1986-03-26 1987-03-26 Steroides comportant un cycle spirannique en position 17, leur procede de preparation et leur utilisation

Publications (1)

Publication Number Publication Date
KR880701244A true KR880701244A (ko) 1988-07-26

Family

ID=9333576

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019870701100A KR880701244A (ko) 1986-03-26 1987-11-25 위치 17에 스피로 고리가 있는 스테로이드, 이들의 제조 방법 및 중간체 약제로서 이들의 사용, 및 이들을 함유하는 약제학적 조성물

Country Status (27)

Country Link
US (1) US4900725A (ko)
EP (1) EP0262188B1 (ko)
JP (2) JP2684180B2 (ko)
KR (1) KR880701244A (ko)
CN (1) CN1021445C (ko)
AU (1) AU604692B2 (ko)
CA (1) CA1299169C (ko)
DK (1) DK174211B1 (ko)
ES (1) ES2004268A6 (ko)
FI (1) FI87078C (ko)
FR (1) FR2596395B1 (ko)
GR (1) GR870471B (ko)
HU (1) HU198509B (ko)
IE (1) IE60143B1 (ko)
IL (1) IL82004A0 (ko)
MA (1) MA20918A1 (ko)
MX (1) MX5712A (ko)
NZ (1) NZ219776A (ko)
OA (1) OA08505A (ko)
PH (1) PH25612A (ko)
PT (1) PT84554B (ko)
SU (1) SU1715205A3 (ko)
TN (1) TNSN87042A1 (ko)
TR (1) TR23117A (ko)
WO (1) WO1987005908A1 (ko)
YU (1) YU53387A (ko)
ZA (1) ZA872130B (ko)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0306846A3 (de) * 1987-09-11 1990-05-02 Dr. Karl Thomae GmbH Neue synergistische Kombination bestehend aus einem Phosphodiesterase-Hemmer und einem Thromboxan-A2-Antagonisten und deren Verwendung bzw. Herstellung
FR2620707B1 (fr) * 1987-09-18 1989-12-08 Roussel Uclaf Nouveaux steroides comportant un cycle spirannique a 3, 4 ou 6 chainons en position 17, leur procede et des intermediaires de preparation, leur application comme medicaments et les compositions pharmaceutiques les renfermant
DE3921059A1 (de) * 1989-06-23 1991-01-10 Schering Ag 11(beta)-aryl-4-estrene, verfahren zu ihrer herstellung sowie deren verwendung als arzneimittel
FR2651233B1 (fr) * 1989-08-23 1991-12-13 Roussel Uclaf Nouveaux acides omega-phenylamino alcanouiques substitues sur le noyau aromatique par un radical derive de 19-norsterouides, leur procede de preparation, leur application a titre de medicaments et les compositions les renfermant.
FR2654337B1 (fr) * 1989-11-15 1994-08-05 Roussel Uclaf Nouvelles microspheres injectables biodegradables procede de preparation et suspensions injectables les renfermant.
DE4018168A1 (de) * 1990-06-01 1991-12-05 Schering Ag Ausgangsverbindungen fuer die herstellung von 10ss-h-steroiden und ein verfahren zur herstellung dieser ausgangsverbindungen
ZA929315B (en) * 1991-12-20 1993-05-24 Akzo Nv 17-spirofuran-3'-ylidene steroids.
CA2100514C (en) * 1992-07-29 2005-03-29 Johannes A. M. Hamersma 17-spiromethylene steroids
FR2757399B1 (fr) * 1996-12-23 1999-12-17 Hoechst Marion Roussel Inc Application de composes steroides substitues en 11 pour la fabrication de medicaments ayant une activite estrogene dissociee
US6020328A (en) * 1998-03-06 2000-02-01 Research Triangle Institute 20-keto-11β-arylsteroids and their derivatives having agonist or antagonist hormonal properties
DE69942578D1 (de) 1998-05-22 2010-08-26 Univ R Bifunktionelle moleküle sowie darauf basierende therapien.
US5962444A (en) * 1998-05-29 1999-10-05 Research Triangle Institute 17β-nitro-11β-arylsteroids and their derivatives having agonist or antagonist hormonal properties
US6262042B1 (en) * 1998-05-29 2001-07-17 Research Triangle Institute 17β-amino and hydroxylamino-11β-arylsteroids and their derivatives having agonist or antagonist hormonal properties
FR2789393B1 (fr) * 1999-02-05 2001-10-12 Centre Nat Rech Scient Lactol steroidique
EP3827747A1 (en) 2005-04-28 2021-06-02 Otsuka Pharmaceutical Co., Ltd. Pharma-informatics system
US9062126B2 (en) 2005-09-16 2015-06-23 Raptor Pharmaceuticals Inc. Compositions comprising receptor-associated protein (RAP) variants specific for CR-containing proteins and uses thereof
DE102006054535A1 (de) * 2006-11-15 2008-05-21 Bayer Schering Pharma Aktiengesellschaft Progesteronrezeptorantagonisten
GB0711948D0 (en) * 2007-06-20 2007-08-01 Bionature E A Ltd Neurosteriod compounds
NZ616673A (en) 2009-02-20 2014-08-29 To Bbb Holding B V Glutathione-based drug delivery system
ES2942923T3 (es) 2009-05-06 2023-06-07 Laboratory Skin Care Inc Composiciones de administración dérmica que comprenden complejos de agente activo-partículas de fosfato de calcio y métodos de uso de las mismas
DE102009034362A1 (de) * 2009-07-20 2011-01-27 Bayer Schering Pharma Aktiengesellschaft 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-aryl-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Behandlung von Krankheiten
DE102009034366A1 (de) 2009-07-20 2011-01-27 Bayer Schering Pharma Aktiengesellschaft 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-methylenoxyalkylenaryl-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Behandlung von Krankheiten
DE102009034368A1 (de) 2009-07-20 2011-01-27 Bayer Schering Pharma Aktiengesellschaft 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-acyloxyalkylenphenyl-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Behandlung von Krankheiten
DE102009034367A1 (de) 2009-07-20 2011-01-27 Bayer Schering Pharma Aktiengesellschaft 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-benzyliden-Derivate, Verfahren zu deren Herstellung und deren Verwendung zur Behandlung von Krankheiten
DE102009034526A1 (de) 2009-07-21 2011-02-10 Bayer Schering Pharma Aktiengesellschaft 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-ethinylphenyl-Derivate, Verfahren zu deren Herstellung und deren Verwendung zur Behandlung von Krankheiten
DE102009034525A1 (de) 2009-07-21 2011-01-27 Bayer Schering Pharma Aktiengesellschaft 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-aryl-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Behandlung von Krankheiten
EA021840B1 (ru) * 2009-09-11 2015-09-30 Бионейчэ Е.А. Лтд. Применение стероидных соединений при воспалительных и аутоиммунных заболеваниях
DE102010007722A1 (de) 2010-02-10 2011-08-11 Bayer Schering Pharma Aktiengesellschaft, 13353 Progesteronrezeptorantagonisten
DE102010007719A1 (de) 2010-02-10 2011-08-11 Bayer Schering Pharma Aktiengesellschaft, 13353 Progesteronrezeptorantagonisten
US9096641B2 (en) * 2013-06-05 2015-08-04 Evestra, Inc. Imidazolyl progesterone antagonists

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3509135A (en) * 1968-07-26 1970-04-28 Searle & Co 3-oxygenated 4'-5 - dihydrospiro(estra-4,9-diene-17,2'(3'h)-furans) and congeners
US3764596A (en) * 1971-06-22 1973-10-09 Sandoz Ag 17-dihydrofuranyl-substituted steroids
FR2496669A1 (fr) * 1980-12-23 1982-06-25 Roussel Uclaf Nouveaux derives steroides 3-ceto4 ou1-4 substitues en position 7, leur procede de preparation et leur application comme medicaments
FR2528434B1 (fr) * 1982-06-11 1985-07-19 Roussel Uclaf Nouveaux 19-nor steroides substitues en 11b et eventuellement en 2, leur procede de preparation et leur application comme medicament
ZA8231B (en) * 1981-01-09 1982-11-24 Roussel Uclaf New 11 -substituted steroid derivatives, their preparation, their use as medicaments, the compositions containing them and the new intermediates thus obtained
DE3410880A1 (de) * 1984-03-21 1985-10-03 Schering AG, Berlin und Bergkamen, 1000 Berlin 17-substituierte estradiene und estratriene

Also Published As

Publication number Publication date
CN1021445C (zh) 1993-06-30
CN87103193A (zh) 1988-01-13
NZ219776A (en) 1990-03-27
WO1987005908A1 (fr) 1987-10-08
EP0262188A1 (fr) 1988-04-06
IL82004A0 (en) 1987-10-20
FR2596395A1 (fr) 1987-10-02
HUT46037A (en) 1988-09-28
JPS63502902A (ja) 1988-10-27
DK618287A (da) 1988-01-22
CA1299169C (fr) 1992-04-21
ES2004268A6 (es) 1988-12-16
PT84554B (pt) 1989-11-10
MX5712A (es) 1993-11-01
FI87078C (fi) 1992-11-25
EP0262188B1 (fr) 1990-11-14
DK174211B1 (da) 2002-09-23
FI875202A0 (fi) 1987-11-25
SU1715205A3 (ru) 1992-02-23
AU7167487A (en) 1987-10-20
GR870471B (en) 1987-07-30
FR2596395B1 (fr) 1989-05-26
JP2652007B2 (ja) 1997-09-10
YU53387A (en) 1988-08-31
ZA872130B (en) 1988-05-25
JPH08311094A (ja) 1996-11-26
FI87078B (fi) 1992-08-14
OA08505A (fr) 1988-07-29
PT84554A (fr) 1987-04-01
TR23117A (tr) 1989-04-03
HU198509B (en) 1989-10-30
JP2684180B2 (ja) 1997-12-03
IE60143B1 (en) 1994-06-01
TNSN87042A1 (fr) 1990-01-01
FI875202A (fi) 1987-11-25
MA20918A1 (fr) 1987-10-01
PH25612A (en) 1991-08-08
US4900725A (en) 1990-02-13
AU604692B2 (en) 1991-01-03
DK618287D0 (da) 1987-11-25
IE870772L (en) 1987-09-26

Similar Documents

Publication Publication Date Title
KR880701244A (ko) 위치 17에 스피로 고리가 있는 스테로이드, 이들의 제조 방법 및 중간체 약제로서 이들의 사용, 및 이들을 함유하는 약제학적 조성물
DE3069468D1 (en) Quinazoline derivatives, processes for their preparation, compositions containing them and their use as anti-cancer agents
IL84522A0 (en) Imidazopyridine derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
IL55183A0 (en) Novel imidazoquinazoline derivatives, their preparation and pharmaceutical compositions containing them
IL55465A0 (en) Novel thiazine derivatives,their preparation and pharmaceutical compositions containing them
IT1213379B (it) Tiazolo [4,5-c]chinoline, procedimento per la loro preparazione e composizioni farmaceutiche che le contengono.
IL89205A (en) Chloroaniline derivatives, their preparation and pharmaceutical compositions containing them
IL83432A (en) N-phenylcarboxamide derivatives,their preparation and pharmaceutical compositions containing them
IL54519A0 (en) 2-diarylalkyl-1-azabicyclo (2,2,2) octanes, their preparation and pharmaceutical compositions containing them
IL51581A0 (en) New 2,3-dihydro-imidazo(2,1-b)thiazole derivatives their preparation and pharmaceutical compositions containing the
FR2599742B1 (fr) Composes antibiotiques, leur preparation et les compositions pharmaceutiques qui les contiennent
IL56078A (en) 9-hydrazono-6,7,8,9-tetrahydro-4h-pyrido(1,2-a)-pyrimidin-4-one derivatives,their preparation and pharmaceutical compositions containing them
KR880700814A (ko) 아미노글리코사이드 스테로이드, 이의 제조방법, 이의 용도 및 이를 함유하는 약제학적 조성물
PT73740B (en) Novel benzoxazolinones substituted in the 6-position by an amino-alcohol chain or amino-ketone chain their preparation and their use in pharmaceutical preparations
AR243499A1 (es) Un procedimiento para la preparacion de derivados de sulfonanilida.
IL84128A (en) 3-propenylcephem derivatives, their preparation and pharmaceutical compositions containing them
KR880700815A (ko) 아미노글리코사이드 스테로이드, 그의 제조방법, 그의 용도 및 이를 함유하는 약제학적 조성물
IT8919172A0 (it) Composizioni contenenti bismuto idonee per uso terapeutico.
DE2860651D1 (en) 3"-n-demethyl-3"-n-substituted-4,6-di-0-(aminoglycosyl)-1,3-diaminocyclitols, methods for their preparation and their application as antibiotics
IT8424159A0 (it) Composizioni farmaceutiche antitumorali e procedimento per laloro preparazione.
IL83753A0 (en) Sulphonamidoethyl derivatives,their preparation and pharmaceutical compositions containing them
IL61240A0 (en) Quinazoline derivatives, their preparation and pharmaceutical compositions containing them
PH24972A (en) Labdane compounds,pharmaceutical composition and use
PT84339A (pt) 1,6-naphthyridine derivatives process for the preparation thereof and pharmaceutical compositions containing them
IL67263A (en) Azino rifamycins,their preparation and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E601 Decision to refuse application